CHIKITSAK LIFESCIENCES PRIVATE LIMITED

In their own words

Non-communicable diseases (NCDs) – cardiovascular diseases (CVDs), chronic respiratory diseases, diabetes and cancer – are a major threat to health and economic growth of Indian population. World Health Organization (WHO) report suggests that 1 in 4 Indian adult risks dying from an NCD before they reach the age of 70. It is also estimated that collectively Indians would lose $3.55 trillion during 2012 – 2030 due health expenditures and productivity loss. Chikitsak LifeSciences provides a cost-effective large scale NCD screening solution for underserved populations by leveraging technology and community outreach model. It is creating a pool of dedicated, trained; technology enabled healthcare micro-entrepreneurs called Chikitsaks. These primary healthcare workers serve as a bridge between the healthcare ecosystem and communities, in both rural India and urban India. Chikitsak LifeSciences leverages a proprietary technology solution that has a clinical decision support system bundled with certified medical devices. This allows for seamless data transfer from medical devices without manual data entry and thus reducing data entry/omission errors. This in turn is integrated with an enterprise grade electronic health records system for health data storage and retrievals.Key Value Propositions − 15 screening tests for NCDs in 10 minutes − Portable and easily operable in rural community setting − Income generation model for sustainable growth − Clinical grade medical devices that are FDA or CE certified − Seamless wireless data transfer from screening devices to servers to prevent data omissions & errors − Tablet based technology solution for workflow automation and governance

Written by the company on its public Startup India profile. Not verified by us.